Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
Details for Australian Patent Application No. 2004222097 (hide)
International Classifications
Event Publications
6 October 2005 PCT application entered the National Phase
PCT publication WO2004/083198 Priority application(s): WO2004/083198
27 October 2005 Amendment Made
The nature of the amendment is: Amend the invention title to read Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
7 June 2007 Application Accepted
Published as AU-B-2004222097
14 June 2007 Change of Name(s) of Applicant(s), Section 104
Santhera Pharmaceuticals (Schweiz) GmbH The name of the applicant has been changed to Santhera Pharmaceuticals (Schweiz) AG
4 October 2007 Standard Patent Sealed
15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004222098-Vibration reduction apparatus for power tool and power tool incorporating such apparatus
2004222096-Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser